Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations.
DNA damage
NHEJ
Super-resolution microscopy
TDP-43 mutations
Journal
Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600
Informations de publication
Date de publication:
09 09 2020
09 09 2020
Historique:
received:
20
10
2019
accepted:
08
06
2020
entrez:
10
9
2020
pubmed:
11
9
2020
medline:
27
8
2021
Statut:
epublish
Résumé
Pathological forms of TAR DNA-binding protein 43 (TDP-43) are present in motor neurons of almost all amyotrophic lateral sclerosis (ALS) patients, and mutations in TDP-43 are also present in ALS. Loss and gain of TDP-43 functions are implicated in pathogenesis, but the mechanisms are unclear. While the RNA functions of TDP-43 have been widely investigated, its DNA binding roles remain unclear. However, recent studies have implicated a role for TDP-43 in the DNA damage response. We used NSC-34 motor neuron-like cells and primary cortical neurons expressing wildtype TDP-43 or TDP-43 ALS associated mutants (A315T, Q331K), in which DNA damage was induced by etoposide or H We demonstrate that wildtype TDP-43 is recruited to sites of DNA damage where it participates in classical NHEJ DNA repair. However, ALS-associated TDP-43 mutants lose this activity, which induces DNA damage. Furthermore, DNA damage is present in mice displaying TDP-43 pathology, implying an active role in neurodegeneration. Additionally, DNA damage triggers features typical of TDP-43 pathology; cytoplasmic mis-localisation and stress granule formation. Similarly, inhibition of NHEJ induces TDP-43 mis-localisation to the cytoplasm. This study reveals that TDP-43 functions in DNA repair, but loss of this function triggers DNA damage and is associated with key pathological features of ALS.
Sections du résumé
BACKGROUND
Pathological forms of TAR DNA-binding protein 43 (TDP-43) are present in motor neurons of almost all amyotrophic lateral sclerosis (ALS) patients, and mutations in TDP-43 are also present in ALS. Loss and gain of TDP-43 functions are implicated in pathogenesis, but the mechanisms are unclear. While the RNA functions of TDP-43 have been widely investigated, its DNA binding roles remain unclear. However, recent studies have implicated a role for TDP-43 in the DNA damage response.
METHODS
We used NSC-34 motor neuron-like cells and primary cortical neurons expressing wildtype TDP-43 or TDP-43 ALS associated mutants (A315T, Q331K), in which DNA damage was induced by etoposide or H
RESULTS
We demonstrate that wildtype TDP-43 is recruited to sites of DNA damage where it participates in classical NHEJ DNA repair. However, ALS-associated TDP-43 mutants lose this activity, which induces DNA damage. Furthermore, DNA damage is present in mice displaying TDP-43 pathology, implying an active role in neurodegeneration. Additionally, DNA damage triggers features typical of TDP-43 pathology; cytoplasmic mis-localisation and stress granule formation. Similarly, inhibition of NHEJ induces TDP-43 mis-localisation to the cytoplasm.
CONCLUSIONS
This study reveals that TDP-43 functions in DNA repair, but loss of this function triggers DNA damage and is associated with key pathological features of ALS.
Identifiants
pubmed: 32907630
doi: 10.1186/s13024-020-00386-4
pii: 10.1186/s13024-020-00386-4
pmc: PMC7488163
doi:
Substances chimiques
DNA-Binding Proteins
0
TARDBP protein, human
0
TDP-43 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
51Références
DNA Repair (Amst). 2008 Oct 1;7(10):1765-71
pubmed: 18675941
J Mol Biol. 2014 Oct 9;426(20):3376-88
pubmed: 25128619
Semin Neurol. 2007 Feb;27(1):48-57
pubmed: 17226741
Rev Neurosci. 2007;18(2):115-36
pubmed: 17593875
Angew Chem Int Ed Engl. 2008;47(33):6172-6
pubmed: 18646237
J Exp Med. 2011 Nov 21;208(12):2429-47
pubmed: 22084410
Neurotox Res. 2015 Aug;28(2):138-46
pubmed: 26013250
Mol Neurodegener. 2014 Sep 20;9:38
pubmed: 25239657
PLoS Genet. 2008 Jun 27;4(6):e1000110
pubmed: 18584027
Neuron. 2014 Jul 16;83(2):266-282
pubmed: 25033177
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7701-E7709
pubmed: 27849576
J Comp Neurol. 2007 Jan 1;500(1):20-46
pubmed: 17099894
Cell Cycle. 2008 Sep 15;7(18):2902-6
pubmed: 18769152
Mol Cell Neurosci. 2017 Sep;83:46-54
pubmed: 28687523
Acta Neuropathol. 2015 Nov;130(5):643-60
pubmed: 26197969
Mutat Res. 2008 May 10;641(1-2):43-7
pubmed: 18423498
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4696-4705
pubmed: 30770445
Transl Neurodegener. 2017 Jun 16;6:15
pubmed: 28638596
J Biol Chem. 2013 Aug 23;288(34):24731-41
pubmed: 23833192
Prog Biophys Mol Biol. 2015 Mar;117(2-3):194-205
pubmed: 25550082
Neuron. 2013 Aug 7;79(3):416-38
pubmed: 23931993
Curr Alzheimer Res. 2011 May;8(3):273-94
pubmed: 21222600
Hum Mol Genet. 2018 Aug 1;27(15):2658-2670
pubmed: 29750243
Acta Neuropathol Commun. 2015 Jun 25;3:36
pubmed: 26108367
Nat Commun. 2018 Sep 24;9(1):3882
pubmed: 30250272
Am J Hum Genet. 2004 Jun;74(6):1128-35
pubmed: 15106121
J Clin Invest. 2014 Mar;124(3):981-99
pubmed: 24509083
J Neurosci. 2010 May 5;30(18):6171-7
pubmed: 20445041
Science. 2008 Mar 21;319(5870):1668-72
pubmed: 18309045
Neural Regen Res. 2017 Sep;12(9):1441-1442
pubmed: 29089988
Neuron. 2019 Sep 4;103(5):802-819.e11
pubmed: 31272829
J Mol Biol. 2003 Feb 7;326(1):93-103
pubmed: 12547193
Mutat Res. 2011 Jun 3;711(1-2):61-72
pubmed: 21329706
Acta Neuropathol. 2015 Nov;130(5):679-97
pubmed: 26298469
Hum Mol Genet. 2017 Aug 1;26(15):2882-2896
pubmed: 28481984
J Phys Chem Lett. 2015 Feb 5;6(3):374-82
pubmed: 26261950
Bioinformatics. 2014 Aug 15;30(16):2389-90
pubmed: 24771516
Brain Res. 2009 Dec 11;1305:168-82
pubmed: 19815002
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E736-45
pubmed: 23382207
Hum Mol Genet. 2009 Oct 15;18(R2):R156-62
pubmed: 19808791
Cancer Res. 2006 May 15;66(10):5354-62
pubmed: 16707462
J Neurochem. 2009 Nov;111(4):1051-61
pubmed: 19765185
Sci Rep. 2018 May 15;8(1):7551
pubmed: 29765078
In Vivo. 2008 May-Jun;22(3):305-9
pubmed: 18610740
Cell. 2015 Sep 24;163(1):123-33
pubmed: 26406374
Nucleic Acids Res. 2010 Sep;38(17):5706-17
pubmed: 20460465
Acta Neuropathol Commun. 2014 Dec 10;2:172
pubmed: 25492614
PLoS One. 2010 Oct 11;5(10):e13250
pubmed: 20948999
Sci Rep. 2015 Jan 21;5:7924
pubmed: 25603780
Nat Struct Mol Biol. 2011 Jun 12;18(7):822-30
pubmed: 21666678
J Biol Chem. 2010 Jan 1;285(1):608-19
pubmed: 19887443
Nature. 2015 Feb 12;518(7538):254-7
pubmed: 25642960
Nat Commun. 2016 Apr 15;7:11253
pubmed: 27080313
Neural Plast. 2016;2016:3619274
pubmed: 26942017
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7013-7018
pubmed: 28630286
Neuromolecular Med. 2002;2(1):47-60
pubmed: 12230304
Brain Res Bull. 2007 Jun 15;73(1-3):48-54
pubmed: 17499636
Front Cell Neurosci. 2015 Oct 23;9:423
pubmed: 26557057
Mol Cell Biol. 2014 Apr;34(8):1380-8
pubmed: 24469398
Nat Genet. 2016 Sep;48(9):1037-42
pubmed: 27455347
Sci Rep. 2017 Nov 1;7(1):14882
pubmed: 29093506
Nat Neurosci. 2013 Oct;16(10):1383-91
pubmed: 24036913
Nucleic Acids Res. 1998 Jul 1;26(13):3146-53
pubmed: 9628911
Trends Cell Biol. 2014 Feb;24(2):108-17
pubmed: 24094932
Nat Commun. 2018 Jan 23;9(1):335
pubmed: 29362359
Endocr Relat Cancer. 2009 Sep;16(3):845-56
pubmed: 19509065
Cell. 2018 May 3;173(4):958-971.e17
pubmed: 29628143
PLoS One. 2013 Nov 29;8(11):e81170
pubmed: 24312274
Hum Mol Genet. 2019 Apr 01;28(5):2459-2476
pubmed: 31067307
Nucleic Acids Res. 2017 Dec 15;45(22):12862-12876
pubmed: 29140459
Nucleic Acids Res. 2008 Jun;36(11):3847-56
pubmed: 18503084
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Elife. 2019 Mar 20;8:
pubmed: 30893049
Nat Neurosci. 2017 Sep;20(9):1225-1235
pubmed: 28714954
Anticancer Res. 2000 Sep-Oct;20(5A):3189-93
pubmed: 11062742
J Neurochem. 2018 Feb 27;:
pubmed: 29486049